Axitinib Tablets

Axitinib tablets are a targeted therapy drug. In clinical practice, this product is commonly used for adult patients with advanced renal cell carcinoma (RCC) who have previously failed treatment with a tyrosine kinase inhibitor or cytokine.
Axitinib can block the tyrosine kinase Bcr-Abl in tumor cells, thereby inhibiting cell proliferation. Axitinib can also block the platelet-derived growth factor receptor (PDGFR) and C-KIT tyrosine kinase in tumor cells, thereby inhibiting the spread of tumor cells.